Russell Investments Group
LJPC

Russell Investments Group’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Russell Investments Group’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-5,568
Closed -$21K – 3286
2020
Q4 		$21K Hold
5,568
– – ﹤0.01% 2981
2020
Q3 		$22K Hold
5,568
– – ﹤0.01% 3135
2020
Q2 		$23K Buy
+5,568
New +$33.9K ﹤0.01% 3048

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Russell Investments Group's LJPC Position: Q1 2021 in Review

Russell Investments Group sold out of La Jolla Pharmaceutical Company (LJPC) in Q1 2021, closing a stake of 5,568 shares — an estimated $21K sold.

Russell Investments Group first reported a position in LJPC in Q2 2020 and held it in 3 quarters. The position peaked at $23K in Q2 2020. 76 funds tracked by Wall St. Rank hold LJPC as of Q1 2021.

  • Russell Investments Group reported no remaining La Jolla Pharmaceutical Company position as of Q1 2021 after selling out during the quarter.
  • Russell Investments Group sold 5,568 La Jolla Pharmaceutical Company shares in Q1 2021, an estimated $21K.
  • Russell Investments Group first reported a position in La Jolla Pharmaceutical Company in Q2 2020 and held it in 3 quarters.
  • Russell Investments Group's La Jolla Pharmaceutical Company position peaked at $23K in Q2 2020.
  • 76 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q1 2021.

Based on Russell Investments Group's 13F filing for Q1 2021, filed 10 May 2021.